Internet Travel News (press release), UK - 15 hours ago He is also a board member of the Caring for Carcinoid Foundation. Rusty Rueff - Rueff was most recently CEO of SNOCAP until its sale to imeem in April 2008. ... |
By Cancer
3971 items (3971 unread) in 83 feeds
Click on blue folders to expand
Adrenal Gland Cancer
(438)
Ampulla Of Vater
(26)
Anal Cancer
(272)
Angiosarcoma
(69)
Appendix Cancer
(34)
Bile Duct Cancer
(525)
Brain & CNS
(753)
Carcinoid
(165)
Endocrine/Neuroendocrine
(256)
Gall Bladder Cancer
(88)
General
(109)
Hemangioendothelioma
(28)
HemeOnc
(443)
Hepatoblastoma
(61)
Pancreas
(48)
Phyllodes
(12)
Rhabdomyosarcoma
(214)
Sarcoma
(287)
Google - Carcinoid (50 unread)
-
Glassdoor.com reveals board members - Internet Travel News (press release)
Posted: May 14th, 2008, 5:10am EDT
-
Former Star reporter, bon vivant and world traveller dies - Toronto Star
Posted: May 13th, 2008, 2:35am EDT
Former Star reporter, bon vivant and world traveller dies
Toronto Star, Canada - May 13, 2008
King, a valued Star staffer for a decade and later a contributor of travel articles, died Friday after a 13-year battle with a carcinoid tumour, ... -
Coup of Joe - National Post
Posted: May 13th, 2008, 2:13am EDT
Coup of Joe
National Post, Canada - May 13, 2008
... both in the pool and on her bike, lifting weights and helping to run a business -- all while receiving treatment for carcinoid, a neuroendocrine cancer. -
Lexicon Pharmaceuticals to Present At the Bank of America Health ... - Primenewswire (press release)
Posted: May 8th, 2008, 2:04pm EDT
Lexicon Pharmaceuticals to Present At the Bank of America Health ...
Primenewswire (press release), CA - May 8, 2008
... underway for such areas of major unmet medical need as irritable bowel syndrome, cognitive disorders, autoimmune diseases, and carcinoid syndrome. ... -
Gluteal Nodules in Patients with Metastatic Midgut Carcinoid ... - Journal of Clinical Endocrinology and Metabolism
Posted: May 7th, 2008, 1:09pm EDT
Gluteal Nodules in Patients with Metastatic Midgut Carcinoid ...
Journal of Clinical Endocrinology and Metabolism, MD - May 7, 2008
Context and Objectives: We were referred a patient with metastatic well-differentiated endocrine tumor of the small intestine (midgut carcinoid) in whom ... -
BACK to LIFE - Lancaster Newspapers
Posted: May 5th, 2008, 12:00pm EDT
BACK to LIFE
Lancaster Newspapers, PA - May 5, 2008
and he told me about carcinoid cancer. I needed a miracle and I got a miracle." Carcinoid cancer (which Mitchell explains means "acts like" cancer) has been ... -
Relay for Life - Salisbury Post
Posted: May 3rd, 2008, 1:44am EDT
Relay">[HtTpQGJ9H8ZSwps7tSPw">Relay] for Life
Salisbury Post, NC - May 3, 2008
James Phelps, of Rockwell, is a nine-year survivor of carcinoid syndrome, a type of cancer that attacked his stomach and liver. ... -
Lexicon Pharmaceuticals Reports 2008 First Quarter Financial Results - PharmaLive.com (press release)
Posted: April 30th, 2008, 6:05am EDT
Lexicon Pharmaceuticals Reports 2008 First Quarter Financial Results
PharmaLive.com (press release), PA - Apr 30, 2008
Lexicon commenced initial Phase 1 dosing for LX1032, the company’s oral drug candidate for managing gastrointestinal symptoms associated with carcinoid ... -
The health-fulfilling prophecy - National Post
Posted: April 29th, 2008, 3:34pm EDT
The health-fulfilling prophecy
National Post, Canada - Apr 29, 2008
My friend Catherine Blackwood is preparing to complete her first triathlon on June 1, despite being diagnosed with carcinoid, a neuroendocrine cancer, ... -
Lexicon Pharmaceuticals Reports 2008 First Quarter Financial Results - CNNMoney.com (press release)
Posted: April 29th, 2008, 2:17pm EDT
Lexicon Pharmaceuticals Reports 2008 First Quarter Financial Results
CNNMoney.com (press release) - 6 hours ago
Lexicon commenced initial Phase 1 dosing for LX1032, the company's oral drug candidate for managing gastrointestinal symptoms associated with carcinoid ... -
Crossfire founders will not give up anytime soon - Asheville Citizen-Times
Posted: April 25th, 2008, 10:16pm EDT
Crossfire founders will not give up anytime soon
Asheville Citizen-Times, NC - Apr 24, 2008
A cancerous carcinoid tumor isn’t going to keep Randy Shepherd from playing in the 15th annual Crossfire vs. ACC All-Stars Classic Saturday night. ... -
Crossfire founders will not give up anytime soon - Asheville Citizen-Times
Posted: April 25th, 2008, 10:16pm EDT
Crossfire founders will not give up anytime soon
Asheville Citizen-Times, NC - Apr 24, 2008
A cancerous carcinoid tumor isn’t going to keep Randy Shepherd from playing in the 15th annual Crossfire vs. ACC All-Stars Classic Saturday night. ... -
Crossfire founders will not give up anytime soon - Asheville Citizen-Times
Posted: April 25th, 2008, 10:16pm EDT
Crossfire founders will not give up anytime soon
Asheville Citizen-Times, NC - Apr 24, 2008
A cancerous carcinoid tumor isn’t going to keep Randy Shepherd from playing in the 15th annual Crossfire vs. ACC All-Stars Classic Saturday night. ... -
Lexicon Pharmaceuticals to Present at Morgan Stanley Global ... - Woodlands Online, LLC
Posted: April 24th, 2008, 3:23pm EDT
Woodlands Online, LLCLexicon Pharmaceuticals to Present at Morgan Stanley Global ...
Woodlands Online, LLC, TX - 5 hours ago
... underway for such areas of major unmet medical need as irritable bowel syndrome, cognitive disorders, autoimmune diseases, and carcinoid syndrome. ...
Lexicon to Report 1Q Financial Results Woodlands Online, LLC
all 2 news articles -
Lexicon Pharmaceuticals to Present At the Morgan Stanley Global ... - CNNMoney.com (press release)
Posted: April 24th, 2008, 2:16pm EDT
Lexicon Pharmaceuticals to Present At the Morgan Stanley Global ...
CNNMoney.com (press release) - 6 hours ago
... underway for such areas of major unmet medical need as irritable bowel syndrome, cognitive disorders, autoimmune diseases, and carcinoid syndrome. ... -
Lexicon Pharmaceuticals to Present At the Morgan Stanley Global ... - Primenewswire (press release)
Posted: April 24th, 2008, 2:03pm EDT
Lexicon Pharmaceuticals to Present At the Morgan Stanley Global ...
Primenewswire (press release), CA - 6 hours ago
... underway for such areas of major unmet medical need as irritable bowel syndrome, cognitive disorders, autoimmune diseases, and carcinoid syndrome. ...
NeurogesX to Present at the 2008 Morgan Stanley Global Healthcare ... NewsBlaze
all 7 news articles -
Lexicon to Report First Quarter 2008 Financial Results On April 29 ... - PharmaLive.com (press release)
Posted: April 21st, 2008, 2:28pm EDT
Lexicon to Report First Quarter 2008 Financial Results On April 29 ...
PharmaLive.com (press release), PA - 6 hours ago
... underway for such areas of major unmet medical need as irritable bowel syndrome, cognitive disorders, autoimmune diseases, and carcinoid syndrome. ... -
Lexicon to Report First Quarter 2008 Financial Results On April 29 ... - CNNMoney.com (press release)
Posted: April 21st, 2008, 2:12pm EDT
Lexicon to Report First Quarter 2008 Financial Results On April 29 ...
CNNMoney.com (press release) - Apr 21, 2008
... underway for such areas of major unmet medical need as irritable bowel syndrome, cognitive disorders, autoimmune diseases, and carcinoid syndrome. ... -
Novartis Q1 Profit Rises 7%; Affirms FY08 Sales Growth Forecast ... - RTT News
Posted: April 21st, 2008, 3:00am EDT
The Money TimesNovartis Q1 Profit Rises 7%; Affirms FY08 Sales Growth Forecast ...
RTT News, NY - Apr 21, 2008
Acromegaly and various neuroendocrine and carcinoid tumors drug Sandostatin's first-quarter sales totaled $269 million, a 5% rise in local currency from the ...
Novartis reports higher sales and Ad-Hoc-News (Pressemitteilung)
* Novartis on track in 2008: Market Wire (press release)
all 155 news articles -
Novartis Q1 Profit Rises 7%; Affirms FY08 Sales Growth Forecast ... - RTT News
Posted: April 21st, 2008, 3:00am EDT
RTT NewsNovartis Q1 Profit Rises 7%; Affirms FY08 Sales Growth Forecast ...
RTT News, NY - Apr 21, 2008
Acromegaly and various neuroendocrine and carcinoid tumors drug Sandostatin's first-quarter sales totaled $269 million, a 5% rise in local currency from the ... -
Novartis’ nonsmall cell lung cancer drug ASA404 has entered a ... - FDA news (subscription)
Posted: April 18th, 2008, 3:41pm EDT
Novartis’ nonsmall cell lung cancer drug ASA404 has entered a ...
FDA news (subscription), VA - Apr 18, 2008
The other therapies include RAD001 (renal cell carcinoma and other cancers), SOM230 (Cushing’s disease/refractory carcinoid tumors, acromegaly), ... -
Callisto Pharmaceuticals' Interim Phase II Data Of Atiprimod In ... - Medical News Today (press release)
Posted: April 16th, 2008, 5:06am EDT
Callisto Pharmaceuticals' Interim Phase II Data Of Atiprimod In ...
Medical News Today (press release), UK - 15 hours ago
Atiprimod has been given orphan drug designation to treat carcinoid cancer. "We had previously hoped to release the interim data from this trial during the ... -
Callisto Pharmaceuticals' Interim Phase II Data Of Atiprimod In ... - Medical News Today (press release)
Posted: April 16th, 2008, 5:06am EDT
Callisto Pharmaceuticals' Interim Phase II Data Of Atiprimod In ...
Medical News Today (press release), UK - Apr 16, 2008
Atiprimod has been given orphan drug designation to treat carcinoid cancer. "We had previously hoped to release the interim data from this trial during the ... -
Lexicon Presents Clinical Data for LX6171, a Drug Candidate for ... - Primenewswire (press release)
Posted: April 15th, 2008, 2:07pm EDT
Lexicon Presents Clinical Data for LX6171, a Drug Candidate for ...
Primenewswire (press release), CA - Apr 15, 2008
... underway for such areas of major unmet medical need as irritable bowel syndrome, cognitive disorders, autoimmune diseases, and carcinoid syndrome. ... -
Strength in numbers - National Post
Posted: April 15th, 2008, 10:32am EDT
Strength in numbers
National Post, Canada - Apr 15, 2008
I signed up with my friends the Blackwoods, who are participating to fundraise for and broaden awareness of carcinoid cancer -- a neuroendocrine cancer that ... -
Callisto Pharmaceuticals Announces Presentation on SP-304 at the ... - Business Wire (press release)
Posted: April 15th, 2008, 5:02am EDT
Callisto Pharmaceuticals Announces Presentation on SP-304 at the ...
Business Wire (press release), CA - 15 hours ago
The Company's lead drug in the clinic, Atiprimod, is presently in a Phase II clinical trial in advanced carcinoid cancer, a neuroendocrine tumor, ... -
Callisto Pharmaceuticals’ Interim Phase II Data of Atiprimod in ... - Business Wire (press release)
Posted: April 14th, 2008, 5:03am EDT
Callisto Pharmaceuticals’ Interim Phase II Data of Atiprimod in ...
Business Wire (press release), CA - 15 hours ago
Atiprimod has been given orphan drug designation to treat carcinoid cancer. "We had previously hoped to release the interim data from this trial during the ...
Callisto Pharmaceuticals, Inc. Receives Notice of Delisting From ... FOXBusiness
all 9 news articles -
Novartis puts Antisoma's lung cancer drug into Phase III - Pharma Times (subscription)
Posted: April 14th, 2008, 3:45am EDT
ASA404, A Novel Cancer Agent, Begins Pivotal Trial To Explore New ...
Medical News Today (press release), UK - Apr 14, 2008
... SOM230 (Cushing's disease/refractory carcinoid tumors, acromegaly), LBH589 (cutaneous T-cell lymphoma and other cancers), EPO906 (ovarian cancer), ...
Novartis puts Antisoma's lung cancer drug into Phase III Pharma Times (subscription)
all 4 news articles -
Novartis puts Antisoma's lung cancer drug into Phase III - Pharma Times (subscription)
Posted: April 14th, 2008, 3:45am EDT
Novartis puts Antisoma's lung cancer drug into Phase III
Pharma Times (subscription), UK - Apr 14, 2008
The others are RAD001 (renal cell carcinoma and other cancers), SOM230 (Cushing's disease/refractory carcinoid tumors, acromegaly), LBH589 (cutaneous T-cell ... -
Cancer survivor works for ACS to change policy - Hamilton Journal News (subscription)
Posted: April 13th, 2008, 4:25pm EDT
Cancer survivor works for ACS to change policy
Hamilton Journal News (subscription), OH - Apr 13, 2008
But two years after her own victory, she was dealt a new blow when her youngest son, Scott, contracted carcinoid cancer. Devastated by the news, ... -
A blushing bride might know more than she's letting on - Houston Chronicle
Posted: April 13th, 2008, 11:33pm EDT
A blushing bride might know more than she's letting on
Houston Chronicle, United States - Apr 12, 2008
Blushing can be related to internal medical problems such as hypertension or, rarely, carcinoid tumors (not skin cancer). Avoiding alcohol and stress can ... -
ASA404, a novel cancer agent, begins pivotal trial to explore new ... - Prdomain Business Register (press release)
Posted: April 12th, 2008, 12:43am EDT
ASA404, a novel cancer agent, begins pivotal trial to explore new ...
Prdomain Business Register (press release), India - Apr 11, 2008
... SOM230 (Cushing's disease/refractory carcinoid tumors, acromegaly), LBH589 (cutaneous T-cell lymphoma and other cancers), EPO906 (ovarian cancer), ... -
ASA404, a novel cancer agent, begins pivotal trial to explore new ... - Prdomain Business Register (press release)
Posted: April 12th, 2008, 12:43am EDT
ASA404, a novel cancer agent, begins pivotal trial to explore new ...
Prdomain Business Register (press release), India - Apr 11, 2008
... SOM230 (Cushing's disease/refractory carcinoid tumors, acromegaly), LBH589 (cutaneous T-cell lymphoma and other cancers), EPO906 (ovarian cancer), ... -
ASA404, A Novel Cancer Agent, Begins Pivotal Trial to Explore New ... - PharmaLive.com (press release)
Posted: April 11th, 2008, 6:42am EDT
ASA404, A Novel Cancer Agent, Begins Pivotal Trial to Explore New ...
PharmaLive.com (press release), PA - Apr 11, 2008
... SOM230 (Cushing’s disease/refractory carcinoid tumors, acromegaly), LBH589 (cutaneous T-cell lymphoma and other cancers), EPO906 (ovarian cancer), ... -
Callisto Pharmaceuticals Files IND For SP-304 (Guanilib) In ... - Medical News Today (press release)
Posted: April 10th, 2008, 6:42am EDT
Callisto Pharmaceuticals Files IND For SP-304 (Guanilib) In ...
Medical News Today (press release), UK - Apr 10, 2008
The Company's lead drug in the clinic, Atiprimod, is presently in a Phase II clinical trial in advanced carcinoid cancer, a neuroendocrine tumor, ... -
• Those rosy cheeks aren't always the picture of health - The Plain Dealer - cleveland.com
Posted: April 8th, 2008, 2:36am EDT
• Those rosy cheeks aren't always the picture of health
The Plain Dealer - cleveland.com, OH - Apr 8, 2008
Blushing can be related to internal medical problems such as hypertension or, rarely, carcinoid tumors (not skin cancer). Avoiding alcohol and stress can ... -
Callisto Pharmaceuticals Files IND for SP-304 (Guanilib) in ... - Business Wire (press release)
Posted: April 7th, 2008, 5:02am EDT
Callisto Pharmaceuticals Files IND for SP-304 (Guanilib) in ...
Business Wire (press release), CA - 15 hours ago
The Company's lead drug in the clinic, Atiprimod, is presently in a Phase II clinical trial in advanced carcinoid cancer, a neuroendocrine tumor, ... -
Callisto Pharmaceuticals Files IND for SP-304 (Guanilib) in ... - Business Wire (press release)
Posted: April 7th, 2008, 5:02am EDT
Callisto Pharmaceuticals Files IND for SP-304 (Guanilib) in ...
Business Wire (press release), CA - Apr 7, 2008
The Company's lead drug in the clinic, Atiprimod, is presently in a Phase II clinical trial in advanced carcinoid cancer, a neuroendocrine tumor, ... -
Delcath Presents Positive Phase II Data on PHP System in Treatment ... - OneMedPlace
Posted: April 2nd, 2008, 8:37am EDT
Delcath Presents Positive Phase II Data on PHP System in Treatment ...
OneMedPlace, NY - Apr 2, 2008
In 24 patients who presented with diffuse liver metastases of pancreatic neuroendocrine and carcinoid tumors, a total of 68 treatments were administered. ... -
'It helps to do something' - National Post
Posted: April 1st, 2008, 9:47am EDT
National Post'It helps to do something'
National Post, Canada - Apr 1, 2008
It has been about two years since doctors confirmed that Catherine's consistent flushing and fatigue were symptoms of carcinoid/neuroendocrine syndrome. ... -
Diaper Under the Desk – A Daily Reminder of Colon Cancer - WRAL.com
Posted: March 31st, 2008, 5:53am EDT
Diaper Under the Desk – A Daily Reminder of Colon Cancer
WRAL.com, NC - Mar 31, 2008
After the removal of my thyroid, they discovered that the cancer actually originated in my lung - atypical carcinoid tumors. The doctors at UNC Hospitals ... -
Diaper Under the Desk – A Daily Reminder of Colon Cancer - WRAL.com
Posted: March 31st, 2008, 5:53am EDT
Diaper Under the Desk – A Daily Reminder of Colon Cancer
WRAL.com, NC - Mar 31, 2008
After the removal of my thyroid, they discovered that the cancer actually originated in my lung - atypical carcinoid tumors. The doctors at UNC Hospitals ... -
OTCPicks.com Stocks to Watch for Thursday, March 27th JPCI - TransWorldNews (press release)
Posted: March 26th, 2008, 7:05pm EDT
OTCPicks.com Stocks to Watch for Thursday, March 27th JPCI
TransWorldNews (press release), GA - 1 hour ago
... multiple myeloma, and glioblastoma; Phase II clinical trials in combination with Avastin for the treatment of carcinoid cancer; Phase Ib Part A and B ... -
OTCPicks.com Stocks to Watch for Thursday, March 27th JPCI - TransWorldNews (press release)
Posted: March 26th, 2008, 7:05pm EDT
OTCPicks.com Stocks to Watch for Thursday, March 27th JPCI
TransWorldNews (press release), GA - Mar 26, 2008
... multiple myeloma, and glioblastoma; Phase II clinical trials in combination with Avastin for the treatment of carcinoid cancer; Phase Ib Part A and B ... -
OTCPicks.com Stocks to Watch for Thursday, March 27th JPCI - TransWorldNews (press release)
Posted: March 26th, 2008, 7:05pm EDT
OTCPicks.com Stocks to Watch for Thursday, March 27th JPCI
TransWorldNews (press release), GA - Mar 26, 2008
... multiple myeloma, and glioblastoma; Phase II clinical trials in combination with Avastin for the treatment of carcinoid cancer; Phase Ib Part A and B ... -
BUYINS.NET: GLRE, HYDG, IPSU, MIPI, RACK, ICPR Have Also Been ... - Trading Markets (press release)
Posted: March 24th, 2008, 3:51am EDT
BUYINS.NET: GLRE, HYDG, IPSU, MIPI, RACK, ICPR Have Also Been ...
Trading Markets (press release), CA - Mar 24, 2008
... such as carcinoid or pheochromocytoma; and Onalta, a clinical-stage radiotherapeutic product candidate for the treatment of somatostatin positive ... -
BUYINS.NET: GLRE, HYDG, IPSU, MIPI, RACK, ICPR Have Also Been ... - Trading Markets (press release)
Posted: March 24th, 2008, 3:51am EDT
BUYINS.NET: GLRE, HYDG, IPSU, MIPI, RACK, ICPR Have Also Been ...
Trading Markets (press release), CA - Mar 24, 2008
... such as carcinoid or pheochromocytoma; and Onalta, a clinical-stage radiotherapeutic product candidate for the treatment of somatostatin positive ... -
Lexicon Pharmaceuticals to Present At the Future Leaders in the ... - Primenewswire (press release)
Posted: March 20th, 2008, 4:37am EDT
Lexicon Pharmaceuticals to Present At the Future Leaders in the ...
Primenewswire (press release), CA - Mar 20, 2008
... underway for such areas of major unmet medical need as irritable bowel syndrome, cognitive disorders, autoimmune diseases, and carcinoid syndrome. ... -
Tuesday, March 18, 2008; Posted: 07:34 AM - Trading Markets (press release)
Posted: March 18th, 2008, 5:40am EDT
Tuesday, March 18, 2008; Posted: 07:34 AM
Trading Markets (press release), CA - 15 hours ago
... underway for such areas of major unmet medical need as irritable bowel syndrome, cognitive disorders, autoimmune diseases, and carcinoid syndrome. ... -
Tuesday, March 18, 2008; Posted: 07:34 AM - Trading Markets (press release)
Posted: March 18th, 2008, 5:40am EDT
Tuesday, March 18, 2008; Posted: 07:34 AM
Trading Markets (press release), CA - Mar 18, 2008
... underway for such areas of major unmet medical need as irritable bowel syndrome, cognitive disorders, autoimmune diseases, and carcinoid syndrome. ...
